Aspira Women’s Health Inc. SEC Filing: Key Updates on Issuer 0000926617
Aspira Women’s Health Inc. (0000926617) recently filed a Form 4 with the Securities and Exchange Commission (SEC), indicating changes in the ownership of company securities by insiders or major shareholders. Form 4 is required to be filed with the SEC whenever there are changes in ownership of a company’s securities by directors, officers, or beneficial owners of more than 10% of the company’s stock.
Aspira Women’s Health Inc. is a healthcare company focused on developing and commercializing diagnostic and screening tests for gynecologic cancers. The company’s innovative products aim to improve the early detection and treatment of ovarian cancer, ultimately enhancing patient outcomes. For more information about Aspira Women’s Health Inc., you can visit their website here.
Form 4 filings provide transparency and accountability regarding insider trading activities within a company, helping investors make informed decisions. Investors and analysts closely monitor these filings to gauge the confidence and sentiment of insiders towards the company’s future prospects.
Read More:
Aspira Women’s Health Inc. Submits SEC Filing (0000926617) – Issuer Update
